EMA Application withdrawn: DuoPlavin (clopidogrel;acetylsalicylic acid) — Sanofi Pharma Bristol-Myers Squibb

View source ↗

Summary

EMA withdrew the application for DuoPlavin (clopidogrel and acetylsalicylic acid) by Sanofi Pharma Bristol-Myers Squibb.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Vascular Diseases
• Vascular Surgical Procedures

Drugs mentioned

• DuoPlavin (clopidogrel; acetylsalicylic acid)
• clopidogrel; acetylsalicylic acid

Snippet

Status: Application withdrawn. Therapeutic area: Vascular Surgical Procedures;Peripheral Vascular Diseases;Myocardial Infarction;Acute Coronary Syndrome. MAH: Sanofi Pharma Bristol-Myers Squibb. Decision date: 31/12/2009